Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07394972

Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

Iron Absorption From Stabilized Lactoferrin: An Experimental Study in Iron Deficient Women (LOBSTER)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Nicole Stoffel · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Lactoferrin (LF) is a natural iron-binding protein found in milk. It exists either in an iron-free state (apo-LF) or bound to iron (holo-LF). Whether LF binds iron to facilitate its absorption and/or to sequester iron from potential enteropathogens remains uncertain. However, while LF is a promising tool for treating iron deficiency, it is sensitive to heat during food processing and to the acidic environment of the human stomach. This degradation often causes LF to lose its functional properties before it can promote iron absorption effectively. This study aims to evaluate whether encapsulating apo-LF (either alone or in combination with iron) can protect LF from digestion and enhance iron absorption. Using a randomized, crossover design, different encapsulation methods will be compared to determine which results in the highest iron absorption in women with iron deficiency. All test compounds will be labeled with stable iron isotopes. Participants will consume the labeled compounds with a test meal or water in a randomized order, allowing for within subject comparisons. Fractional iron absorption will be measured 17 days after administration via the incorporation of labeled iron into red blood cells.

Conditions

Interventions

TypeNameDescription
OTHERFeSO4 + meal-matrixMaize porridge with labelled ferrous sulfate (58Fe)
OTHERFeSO4 + native LF + meal-matrixMaize porridge with labelled ferrous sulfate (58Fe) and lactoferrin
OTHERFeSO4 + NaCas-LF + meal-matrixMaize porridge with labelled ferrous sulfate (57Fe) and in sodium caseinate encapsulated lactoferrin
OTHERNaCas-LF-Fe + meal-matrixMaize porridge with sodium caseinate-lactoferrin-Fe (intrinsically labeled with iron isotope 54)
OTHERFeSO4 + LMP-LF + meal-matrixMaize porridge with labelled ferrous sulfate (54Fe) and low methoxy pectin lactoferrin
OTHERLMP-LF-Fe + meal-matrixMaize porridge with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57)
OTHERNaCas-LF-Fe + waterWater with sodium caseinate-lactoferrin-Fe (intrinsically labelled with iron isotope 54Fe)
OTHERLMP-LF-Fe + waterWater with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57Fe)
OTHERFeSO4 + waterWater with ferrous sulfate (labelled with iron isotope 58Fe)

Timeline

Start date
2026-02-17
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2026-02-06
Last updated
2026-02-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07394972. Inclusion in this directory is not an endorsement.